Treatment with anti-inflammatory drugs in community-acquired pneumonia. - Wikidata - wikimedia - TriplyDB

Treatment with anti-inflammatory drugs in community-acquired pneumonia.

Treatment with anti-inflammatory drugs in community-acquired pneumonia.

http://www.wikidata.org/entity/Q38009864

about

Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: A systematic review and meta-analysis Corticosteroids in the adjunctive therapy of community-acquired pneumonia: an appraisal of recent meta-analyses of clinical trials PPARγ in Bacterial Infections: A Friend or Foe?New aspects in the management of pneumonia Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia.Lung inflammatory pattern and antibiotic treatment in pneumonia β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis.South African guideline for the management of community-acquired pneumonia in adults.Serum levels of immunoglobulins and severity of community-acquired pneumonia.Atorvastatin increases lipopolysaccharide-induced expression of tumour necrosis factor-α-induced protein 8-like 2 in RAW264.7 cells.TLR4 antagonist suppresses airway remodeling in asthma by inhibiting the T-helper 2 response.Adjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal pneumonia in mice.Inhibition of intimal hyperplasia in murine aortic allografts by administration of a small-molecule TLR4 inhibitor TAK-242.CP and CP-PGN protect mice against MRSA infection by inducing M1 macrophages.

P2860

Q26747529-4DD5033D-2236-46F0-9B9E-7E54D161F43C Q26748532-AD76A389-00B0-4477-A91E-C282B0B7E7D3 Q28070173-DE378A94-CF89-43CD-BE3B-B7C261239AAA Q28080025-7B956F5E-5316-42A7-8655-8030B4397C5A Q34209524-9E84D9BA-295F-49D5-B25B-200765CBFFC6 Q35083508-0E43A841-35E5-4D4A-8A1B-3D94DB9CF897 Q38188831-BA33303C-AB71-4798-99A2-395CCB4AAA75 Q39455917-04968951-49AF-4243-9FB2-725A593C8D54 Q40417136-A94DDB8D-3361-408E-B976-CB4B6D28E1E5 Q40817556-8F9C0624-C05C-4B0F-B207-EF596AF13F76 Q41665142-AB903421-A5EF-4A31-A4AA-686A8D255196 Q42239416-A80B0C34-0608-4E8C-9DFA-966FF2DEF5E7 Q45913402-27AC81B7-5D10-45F4-8EBA-A991C5B007C9 Q47136179-081A5037-A172-4CA6-A0E7-E73B4E6AE5C5

P2860

Treatment with anti-inflammatory drugs in community-acquired pneumonia.

http://www.wikidata.org/entity/Q38009864

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Treatment with anti-inflammatory drugs in community-acquired pneumonia.

@en

type

label

Treatment with anti-inflammatory drugs in community-acquired pneumonia.

@en

prefLabel

Treatment with anti-inflammatory drugs in community-acquired pneumonia.

@en

P1433

Q38009864-75A8AD58-08A3-41F7-A358-422A6919958C

P1476

Q38009864-3CAACC2E-DE4B-41B7-922F-C1445034BF7B

P2093

Q38009864-265A8114-0956-4186-B01F-D78D0CC10522

Q38009864-AFC3F3FC-B1EF-4D3E-8C48-BC0BD6AF64B6

Q38009864-C864FB78-01F0-4FDF-8ACA-D20C982CA73C

P2860

Q38009864-048EF5D0-49D8-46D0-AE34-4831E0105EBD

Q38009864-06799DB5-CFDF-445F-BD44-2F748433C4FE

Q38009864-0CC2ED49-E1DB-4A07-BB92-8D5A039AC9B5

Q38009864-12EFA271-C5C1-420E-8FEF-AA746AA50CF8

Q38009864-156861AD-C95E-4EE5-ABBD-9FE707389720

Q38009864-1BC61BEB-1F24-444E-8719-85B02252C20A

Q38009864-1DCAF3C0-7F17-4FE7-853F-9055B8322A1B

Q38009864-1F97336B-6BB6-4D65-AEB5-816B77B71B19

Q38009864-25D9B269-CFA9-446A-9B98-248353A23789

Q38009864-28F61D13-6BF0-4591-8FB9-11B9F1F5DCA3

P304

Q38009864-DDFC065E-761B-46BF-8826-3B3D1C3AB670

P31

Q38009864-3B425902-6B99-44A8-9484-E478B10B2179

P356

Q38009864-EE355053-B0B8-4A9D-BF31-6C8C6A544C36

P407

Q38009864-BDF3849E-C707-4A0A-8430-33D0AA63BDA5

P433

Q38009864-8849739B-84FF-4869-9F91-3C73B1F9FA04

P478

Q38009864-DF12C3E3-4D72-486B-AE9B-23A40F129DF2

P50

Q38009864-C85B33C5-B9CF-4F87-96D2-05155A4B3167

P577

Q38009864-59829411-90AA-4F4E-BFEF-345D1A433C96

P698

Q38009864-ADF4AF99-FBBD-4D6E-94ED-E5A4FA154BF7

P921

Q38009864-967E7A67-9CFC-4B45-B24C-2EA26D6A4342

Q38009864-DDE95C93-2C9D-4822-9E22-7484E5D94C6A

P356

J.1365-2796.2012.02554.X

P1433

Journal of Internal Medicine

P1476

Treatment with anti-inflammatory drugs in community-acquired pneumonia

@en

P2093

E M W van de Garde

http://www.w3.org/2001/XMLSchema#string

G T Rijkers

http://www.w3.org/2001/XMLSchema#string

S C A Meijvis

http://www.w3.org/2001/XMLSchema#string

P2860

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

Structural mechanism for statin inhibition of HMG-CoA reductase

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs

Cytokines and their receptors: an overview.

Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia

Changing patterns of infectious disease.

Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.

P304

25-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2796.2012.02554.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

272

http://www.w3.org/2001/XMLSchema#string

P50

Willem Jan W Bos

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22583070

http://www.w3.org/2001/XMLSchema#string

P921